Grant: Collaborative Health Research Projects
University of Toronto
$120,955.00
Development of a lung ultrasound therapy system for acute respiratory distress syndrome
FY 2018-19
Summary
Treatment of acute respiratory distress syndrome (ARDS), a common disorder in intensive*care units with a mortality rate approaching 40%, is a considerable challenge. In ARDS, the*lungs are filled with fluid resulting in patients drowning in their own fluids. ARDS is one of the*most difficult conditions to treat because of its patchy distribution, where the fluid-filled regions*of the lung are interspersed within the normal lungs, causing conventional treatments to*preferentially affect the normal lungs rather than the injured regions. For instance, mechanical*ventilators, although life-saving, preferentially inflate the normal regions of the lung resulting*in overdistension and injury of the normal lung itself. Similarly, medicines given by inhalation*or injection preferentially affect the normal lungs or other organs in the body. Here we*propose a revolutionary form of personalized and targeted medicine to treat ARDS based on*ultrasound technology and microbubbles (tiny gas bubbles already used clinically for*diagnostic purposes). While the normal regions of lung scatter ultrasound waves (because*ultrasound is blocked by air), the ultrasound waves are able to penetrate the injured (fluidfilled*or collapsed) regions, allowing enhanced delivery of drugs like antibiotics to the*damaged lung. This approach is a revolutionary form of personalized medicine, since it will*allow the delivery of medicines and genes exactly where they are needed in each patient. In*this project, we will develop a clinical prototype of an ultrasound therapy system specifically*for the lungs and optimize treatment protocols using large animal models of ARDS. At the end*of the project, we will translate the study to a Phase I clinical trial in humans.
Program
Collaborative Health Research Projects
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
523598-2018
Name nom
Lee, Warren
Department département
Medicine
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
120955
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
1
Nb partie
1
Application title
Development of a lung ultrasound therapy system for acute respiratory distress syndrome
Keyword
NSERC
Application summary
Treatment of acute respiratory distress syndrome (ARDS), a common disorder in intensive*care units with a mortality rate approaching 40%, is a considerable challenge. In ARDS, the*lungs are filled with fluid resulting in patients drowning in their own fluids. ARDS is one of the*most difficult conditions to treat because of its patchy distribution, where the fluid-filled regions*of the lung are interspersed within the normal lungs, causing conventional treatments to*preferentially affect the normal lungs rather than the injured regions. For instance, mechanical*ventilators, although life-saving, preferentially inflate the normal regions of the lung resulting*in overdistension and injury of the normal lung itself. Similarly, medicines given by inhalation*or injection preferentially affect the normal lungs or other organs in the body. Here we*propose a revolutionary form of personalized and targeted medicine to treat ARDS based on*ultrasound technology and microbubbles (tiny gas bubbles already used clinically for*diagnostic purposes). While the normal regions of lung scatter ultrasound waves (because*ultrasound is blocked by air), the ultrasound waves are able to penetrate the injured (fluidfilled*or collapsed) regions, allowing enhanced delivery of drugs like antibiotics to the*damaged lung. This approach is a revolutionary form of personalized medicine, since it will*allow the delivery of medicines and genes exactly where they are needed in each patient. In*this project, we will develop a clinical prototype of an ultrasound therapy system specifically*for the lungs and optimize treatment protocols using large animal models of ARDS. At the end*of the project, we will translate the study to a Phase I clinical trial in humans.